BACKGROUND: With the combined treatment procedure of isolated limb perfusion (ILP), delayed surgical resection and external beam radiotherapy (EBRT) for locally advanced soft tissue sarcomas (STS) of the extremities, limb salvage rates of more than 80% can be achieved. However, long-term damage to the healthy surrounding tissue cannot be prevented. We studied the late effects on the normal tissue using the LENT-SOMA scoring system. PATIENTS AND METHODS: A total of 32 patients-median age 47 (range 14-71) years-were treated for a locally advanced STS with ILP, surgical resection and often adjuvant 60-70 Gy EBRT. After a median follow-up of 88 (range 17-159) months, the patients were scored, using the LENT-SOMA scales, for the following late t...
BACKGROUND: This feasibility study presents the results of a new intensive treatment regimen for loc...
textabstractPurpose: Because there is no survival benefit of amputation for extremity soft tissue sa...
In the Netherlands, approximately 700 patients are diagnosed with a soft tissue sarcoma each year. T...
Background: With the combined treatment procedure of isolated limb perfusion (ILP), delayed surgical...
Background: With the combined treatment procedure of isolated limb perfusion (ILP), delayed surgical...
Background: Isolated limb perfusion (ILP) with tumor necrosis factor alpha (TNF-alpha) and melphalan...
Background: Standard treatment for localized soft tissue sarcoma (STS) is resection plus adjuvant ra...
Background: The aim was to investigate the value of adjuvant radiotherapy for locally advanced soft ...
BACKGROUND: The aim of this study was to investigate the long-term limb salvage rate and overall sur...
Background: The aim of this study was to investigate the long-term limb salvage rate and overall sur...
Background: The aim was to investigate the value of adjuvant radiotherapy for locally advanced soft ...
Background: The aim of this study was to investigate the long-term limb salvage rate and overall sur...
BACKGROUND: Recurrent extremity soft tissue sarcoma (STS) in a previously operated and irradiated ar...
Purpose: Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-alpha (TNF-alpha), i...
Item does not contain fulltextPURPOSE Because there is no survival benefit of amputation for extremi...
BACKGROUND: This feasibility study presents the results of a new intensive treatment regimen for loc...
textabstractPurpose: Because there is no survival benefit of amputation for extremity soft tissue sa...
In the Netherlands, approximately 700 patients are diagnosed with a soft tissue sarcoma each year. T...
Background: With the combined treatment procedure of isolated limb perfusion (ILP), delayed surgical...
Background: With the combined treatment procedure of isolated limb perfusion (ILP), delayed surgical...
Background: Isolated limb perfusion (ILP) with tumor necrosis factor alpha (TNF-alpha) and melphalan...
Background: Standard treatment for localized soft tissue sarcoma (STS) is resection plus adjuvant ra...
Background: The aim was to investigate the value of adjuvant radiotherapy for locally advanced soft ...
BACKGROUND: The aim of this study was to investigate the long-term limb salvage rate and overall sur...
Background: The aim of this study was to investigate the long-term limb salvage rate and overall sur...
Background: The aim was to investigate the value of adjuvant radiotherapy for locally advanced soft ...
Background: The aim of this study was to investigate the long-term limb salvage rate and overall sur...
BACKGROUND: Recurrent extremity soft tissue sarcoma (STS) in a previously operated and irradiated ar...
Purpose: Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-alpha (TNF-alpha), i...
Item does not contain fulltextPURPOSE Because there is no survival benefit of amputation for extremi...
BACKGROUND: This feasibility study presents the results of a new intensive treatment regimen for loc...
textabstractPurpose: Because there is no survival benefit of amputation for extremity soft tissue sa...
In the Netherlands, approximately 700 patients are diagnosed with a soft tissue sarcoma each year. T...